|
1
|
Metter EJ, Talbot LA, Schrager M and
Conwit R: Skeletal muscle strength as a predictor of all-cause
mortality in healthy men. J Gerontol A Biol Sci Med Sci.
57:B359–B365. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Glass DJ: Signaling pathways perturbing
muscle mass. Curr Opin Clin Nutr Metab Care. 13:225–229. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bodine SC, Latres E, Baumhueter S, Lai VK,
Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K,
et al: Identification of ubiquitin ligases required for skeletal
muscle atrophy. Science. 294:1704–1708. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ramírez C, Russo TL, Sandoval MC, Dentillo
AA, Couto MA, Durigan JL and Salvini TF: Joint inflammation alters
gene and protein expression and leads to atrophy in the tibialis
anterior muscle in rats. Am J Phys Med Rehabil. 90:930–939.
2011.PubMed/NCBI
|
|
5
|
Jackman RW and Kandarian SC: The molecular
basis of skeletal muscle atrophy. Am J Physiol Cell Physiol.
287:C834–C843. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sandri M: Signaling in muscle atrophy and
hypertrophy. Physiology (Bethesda). 23:160–170. 2008. View Article : Google Scholar
|
|
7
|
Powers SK, Kavazis AN and McClung JM:
Oxidative stress and disuse muscle atrophy. J Appl Physiol 1985.
102:2389–2397. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hofer T, Marzetti E, Xu J, Seo AY, Gulec
S, Knutson MD, Leeuwenburgh C and Dupont-Versteegden EE: Increased
iron content and RNA oxidative damage in skeletal muscle with aging
and disuse atrophy. Exp Gerontol. 43:563–570. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Booth FW: Physiologic and biochemical
effects of immobilization on muscle. Clin Orthop Relat Res.
219:15–20. 1987.PubMed/NCBI
|
|
10
|
Thomas DR: Loss of skeletal muscle mass in
aging: Examining the relationship of starvation, sarcopenia and
cachexia. Clin Nutr. 26:389–399. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Léger B, Senese R, Al-Khodairy AW, Dériaz
O, Gobelet C, Giacobino JP and Russell AP: Atrogin-1, MuRF1, and
FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in
skeletal muscle of chronic spinal cord-injured patients. Muscle
Nerve. 40:69–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawano F, Tanihata J, Sato S, Nomura S,
Shiraishi A, Tachiyashiki K and Imaizumi K: Effects of
dexamethasone on the expression of beta(1)-, beta (2)- and beta
(3)-adrenoceptor mRNAs in skeletal and left ventricle muscles in
rats. J Physiol Sci. 59:383–390. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanda F, Takatani K, Okuda S, Matsushita T
and Chihara K: Preventive effects of insulinlike growth factor-I on
steroid-induced muscle atrophy. Muscle Nerve. 22:213–217. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gilson H, Schakman O, Combaret L, Lause P,
Grobet L, Attaix D, Ketelslegers JM and Thissen JP: Myostatin gene
deletion prevents glucocorticoid-induced muscle atrophy.
Endocrinology. 148:452–460. 2007. View Article : Google Scholar
|
|
15
|
Auclair D, Garrel DR, Chaouki Zerouala A
and Ferland LH: Activation of the ubiquitin pathway in rat skeletal
muscle by catabolic doses of glucocorticoids. Am J Physiol.
272:C1007–C1016. 1997.PubMed/NCBI
|
|
16
|
Komamura K, Shirotani-Ikejima H, Tatsumi
R, Tsujita-Kuroda Y, Kitakaze M, Miyatake K, Sunagawa K and Miyata
T: Differential gene expression in the rat skeletal and heart
muscle in glucocorticoid-induced myopathy: Analysis by microarray.
Cardiovasc Drugs Ther. 17:303–310. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qin J, Du R, Yang YQ, Zhang HQ, Li Q, Liu
L, Guan H, Hou J and An XR: Dexamethasone-induced skeletal muscle
atrophy was associated with upregulation of myostatin promoter
activity. Res Vet Sci. 94:84–89. 2013. View Article : Google Scholar
|
|
18
|
Benveniste O, Jacobson L, Farrugia ME,
Clover L and Vincent A: MuSK antibody positive myasthenia gravis
plasma modifies MURF-1 expression in C2C12 cultures and mouse
muscle in vivo. J Neuroimmunol. 170:41–48. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Z, Nakagawa K, Sarkar A, Maruyama J,
Iwasa H, Bao Y, Ishigami-Yuasa M, Ito S, Kagechika H, Hata S, et
al: Screening with a novel cell-based assay for TAZ activators
identifies a compound that enhances myogenesis in C2C12 cells and
facilitates muscle repair in a muscle injury model. Mol Cell Biol.
34:1607–1621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Panossian A and Wikman G: Pharmacology of
Schisandra chinensis Bail.: An overview of Russian research and
uses in medicine. J Ethnopharmacol. 118:183–212. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu Y and Chen DF: Analysis of Schisandra
chinensis and Schisandra sphenanthera. J Chromatogr A.
1216:1980–1990. 2009. View Article : Google Scholar
|
|
22
|
Park S, Hong SM, Ahn IS, Kim YJ and Lee
JB: Huang-Lian-Jie-Du-Tang supplemented with Schisandra chinensis
Baill. and Polygonatum odoratum Druce improved glucose tolerance by
potentiating insulinotropic actions in islets in 90%
pancreatectomized diabetic rats. Biosci Biotechnol Biochem.
73:2384–2392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang J, Shi LL and Zheng YN:
Dibenzocyclooctadiene lignans from Fructus Schisandrae Chinensis
improve glucose uptake in vitro. Nat Prod Commun. 5:231–234.
2010.PubMed/NCBI
|
|
24
|
Kwon DY, Kim S, Yang HJ and Park S: The
lignan-rich fractions of Fructus Schisandrae improve insulin
sensitivity via the PPAR-γ pathways in in vitro and in vivo
studies. J Ethnopharmacol. 135:455–462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jang HI, Do GM, Lee HM, Ok HM, Shin JH and
Kwon O: Schisandra chinensis Baillon regulates the gene expression
of phase II antioxidant/detoxifying enzymes in hepatic damage
induced rats. Nutr Res Pract. 8:272–277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang JM, Ip PS, Che CT and Yeung JH:
Relaxant effects of Schisandra chinensis and its major lignans on
agonists-induced contraction in guinea pig ileum. Phytomedicine.
18:1153–1160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Young Park J, Wook Yun J, Whan Choi Y, Ung
Bae J, Won Seo K, Jin Lee S, Youn Park S, Whan Hong K and Kim CD:
Antihypertensive effect of gomisin A from Schisandra chinensis on
angiotensin II-induced hypertension via preservation of nitric
oxide bioavailability. Hypertens Res. 35:928–934. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pavlatos AM, Fultz O, Monberg MJ, Vootkur
A and Pharmd: Review of oxymetholone: A 17alpha-alkylated
anabolic-androgenic steroid. Clin Ther. 23:789–801; discussion 771.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Del Rio D, Stewart AJ and Pellegrini N: A
review of recent studies on malondialdehyde as toxic molecule and
biological marker of oxidative stress. Nutr Metab Cardiovasc Dis.
15:316–328. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jamall IS and Smith JC: Effects of cadmium
on glutathione peroxidase, superoxide dismutase, and lipid
peroxidation in the rat heart: A possible mechanism of cadmium
cardiotoxicity. Toxicol Appl Pharmacol. 80:33–42. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lowry OH, Rosebrough NJ, Farr AL and
Randall RJ: Protein measurement with the Folin phenol reagent. J
Biol Chem. 193:265–275. 1951.PubMed/NCBI
|
|
32
|
He HJ, Wang GY, Gao Y, Ling WH, Yu ZW and
Jin TR: Curcumin attenuates Nrf2 signaling defect, oxidative stress
in muscle and glucose intolerance in high fat diet-fed mice. World
J Diabetes. 3:94–104. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sedlak J and Lindsay RH: Estimation of
total, protein-bound, and nonprotein sulfhydryl groups in tissue
with Ellman’s reagent. Anal Biochem. 25:192–205. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aebi H: Catalase. Methods in enzymatic
analysis. Bergmeyer HU: Academic Press; New York: pp. 673–686.
1974, View Article : Google Scholar
|
|
35
|
Sun Y, Oberley LW and Li Y: A simple
method for clinical assay of superoxide dismutase. Clin Chem.
34:497–500. 1988.PubMed/NCBI
|
|
36
|
Ogawa T, Nikawa T, Furochi H, Kosyoji M,
Hirasaka K, Suzue N, Sairyo K, Nakano S, Yamaoka T, Itakura M, et
al: Osteoactivin upregulates expression of MMP-3 and MMP-9 in
fibroblasts infiltrated into denervated skeletal muscle in mice. Am
J Physiol Cell Physiol. 289:C697–C707. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tipoe GL, Leung TM, Liong EC, Lau TY, Fung
ML and Nanji AA: Epigallocatechin-3-gallate (EGCG) reduces liver
inflammation, oxidative stress and fibrosis in carbon tetrachloride
(CCl4)-induced liver injury in mice. Toxicology.
273:45–52. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi SR, Chaiwun B, Young L, Cote RJ and
Taylor CR: Antigen retrieval technique utilizing citrate buffer or
urea solution for immunohistochemical demonstration of androgen
receptor in formalin-fixed paraffin sections. J Histochem Cytochem.
41:1599–1604. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ki SH, Yang JH, Ku SK, Kim SC, Kim YW and
Cho IJ: Red ginseng extract protects against carbon
tetrachloride-induced liver fibrosis. J Ginseng Res. 37:45–53.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee HS, Choi SH and Ku SK: Regional
distribution and relative frequency of gastrointestinal endocrine
cells in the ddN mice: An immunohistochemical study. Anat Histol
Embryol. 39:521–528. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song MY, Ku SK, Kim HJ and Han JS: Low
molecular weight fucoidan ameliorating the chronic
cisplatin-induced delayed gastrointestinal motility in rats. Food
Chem Toxicol. 50:4468–4478. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Levene A: Pathological factors influencing
excision of tumours in the head and neck. Part I. Clin Otolaryngol
Allied Sci. 6:145–151. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ludbrook J: Update: Microcomputer
statistics packages. A personal view. Clin Exp Pharmacol Physiol.
24:294–296. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dirks-Naylor AJ and Griffiths CL:
Glucocorticoid-induced apoptosis and cellular mechanisms of
myopathy. J Steroid Biochem Mol Biol. 117:1–7. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Seale JP and Compton MR: Side-effects of
corticosteroid agents. Med J Aust. 144:139–142. 1986.PubMed/NCBI
|
|
46
|
Zoorob RJ and Cender D: A different look
at corticosteroids. Am Fam Physician. 58:443–450. 1998.PubMed/NCBI
|
|
47
|
Bowyer SL, LaMothe MP and Hollister JR:
Steroid myopathy: Incidence and detection in a population with
asthma. J Allergy Clin Immunol. 76:234–242. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Covar RA, Leung DY, McCormick D, Steelman
J, Zeitler P and Spahn JD: Risk factors associated with
glucocorticoid-induced adverse effects in children with severe
asthma. J Allergy Clin Immunol. 106:651–659. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Owczarek J, Jasińska M and
Orszulak-Michalak D: Drug-induced myopathies. An overview of the
possible mechanisms. Pharmacol Rep. 57:23–34. 2005.PubMed/NCBI
|
|
50
|
Fox JG, Cohen BJ and Loew FM: Laboratory
Animal Medicine. Academic Press Inc; Orlando, FL: 1984
|
|
51
|
Gupta AK and Chow M: Prednicarbate
(Dermatop): Profile of a corticosteroid. J Cutan Med Surg.
8:244–247. 2004. View Article : Google Scholar
|
|
52
|
Cho YH, Chung IK, Cheon WH, Lee HS and Ku
SK: Effect of DHU001, a polyherbal formula on formalin-induced paw
chronic inflammation of mice. Toxicol Res (Camb). 27:95–102. 2011.
View Article : Google Scholar
|
|
53
|
Yip AY, Loo WT and Chow LW: Fructus
Schisandrae (Wuweizi) containing compound in modulating human
lymphatic system - a Phase I minimization clinical trial. Biomed
Pharmacother. 61:588–590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tang SH, He RR, Huang T, Wang CZ, Cao YF,
Zhang Y and Kurihara H: The protective effect of Schisandra lignans
on stress-evoked hepatic metastases of P815 tumor cells in
restraint mice. J Ethnopharmacol. 134:141–146. 2011. View Article : Google Scholar
|
|
55
|
Duarte CG, dos Santos GL, Azzolini AE and
de Assis Pandochi AI: The effect of the antithyroid drug
propylthiouracil on the alternative pathway of complement in rats.
Int J Immunopharmacol. 22:25–33. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lee HS, Yang KJ, Shin HD, Park BR, Son CW,
Jang HJ, et al: Single oral dose toxicity studies of Polycan,
β-glucan originated from Aureobasidium in mice. J Toxicol Pub
Health. 21:361–365. 2005.
|
|
57
|
Hengge UR, Baumann M, Maleba R, Brockmeyer
NH and Goos M: Oxymetholone promotes weight gain in patients with
advanced human immunodeficiency virus (HIV-1) infection. Br J Nutr.
75:129–138. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hengge UR, Stocks K, Wiehler H, Faulkner
S, Esser S, Lorenz C, Jentzen W, Hengge D, Goos M, Dudley RE and
Ringham G: Double-blind, randomized, placebo-controlled phase III
trial of oxymetholone for the treatment of HIV wasting. AIDS.
17:699–710. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wyss M and Kaddurah-Daouk R: Creatine and
creatinine metabolism. Physiol Rev. 80:1107–1213. 2000.PubMed/NCBI
|
|
60
|
Balsom PD, Söderlund K and Ekblom B:
Creatine in humans with special reference to creatine
supplementation. Sports Med. 18:268–280. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Fitch CD, Lucy DD, Bornhofen JH and
Dalrymple GV: Creatine metabolism in skeletal muscle. II. creatine
kinetics in man. Neurology. 18:32–42. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Bloch K and Schoenheimer R: Studies in
protein metabolism. XI. The metabolic relation of creatine and
creatinine studies with isotopic nitrogen. J Biol Chem.
131:111–119. 1939.
|
|
63
|
Heymsfield SB, Arteaga C, McManus C, Smith
J and Moffitt S: Measurement of muscle mass in humans: Validity of
the 24-hour urinary creatinine method. Am J Clin Nutr. 37:478–494.
1983.PubMed/NCBI
|
|
64
|
Sala A, Tarnopolsky M, Webber C, Norman G
and Barr R: Serum creatinine: A surrogate measurement of lean body
mass in children with acute lymphoblastic leukemia. Pediatr Blood
Cancer. 45:16–19. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Stimpson SA, Turner SM, Clifton LG, Poole
JC, Mohammed HA, Shearer TW, Waitt GM, Hagerty LL, Remlinger KS,
Hellerstein MK and Evans WJ: Total-body creatine pool size and
skeletal muscle mass determination by creatine-(methyl-D3) dilution
in rats. J Appl Physiol (1985). 112:1940–1948. 2012. View Article : Google Scholar
|
|
66
|
Zhang Y, Huang JJ, Wang ZQ, Wang N and Wu
ZY: Value of muscle enzyme measurement in evaluating different
neuromuscular diseases. Clin Chim Acta. 413:520–524. 2012.
View Article : Google Scholar
|
|
67
|
Choi M, Park H, Cho S and Lee M: Vitamin
D3 supplementation modulates inflammatory responses from the muscle
damage induced by high-intensity exercise in SD rats. Cytokine.
63:27–35. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Cohen I, Bogin E, Chechick A and Rzetelny
V: Biochemical alterations secondary to disuse atrophy in the rat’s
serum and limb tissues. Arch Orthop Trauma Surg. 119:410–417. 1999.
View Article : Google Scholar
|
|
69
|
Orzechowski A, Ostaszewski P, Wilczak J,
Jank M, Bałasińska B, Wareski P and Fuller J Jr: Rats with a
glucocorticoid-induced catabolic state show symptoms of oxidative
stress and spleen atrophy: The effects of age and recovery. J Vet
Med A Physiol Pathol Clin Med. 49:256–263. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Pellegrino MA, D’Antona G, Bortolotto S,
Boschi F, Pastoris O, Bottinelli R, Polla B and Reggiani C:
Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre
type transformation in mice. Exp Physiol. 89:89–100. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Comporti M: Lipid peroxidation and
cellular damage in toxic liver injury. Lab Invest. 53:599–623.
1985.PubMed/NCBI
|
|
72
|
Odabasoglu F, Cakir A, Suleyman H, Aslan
A, Bayir Y, Halici M and Kazaz C: Gastroprotective and antioxidant
effects of usnic acid on indomethacin-induced gastric ulcer in
rats. J Ethnopharmacol. 103:59–65. 2006. View Article : Google Scholar
|
|
73
|
Cheeseman KH and Slater TF: An
introduction to free radical biochemistry. Br Med Bull. 49:481–493.
1993.PubMed/NCBI
|
|
74
|
Süleyman H, Cadirci E, Albayrak A, Polat
B, Halici Z, Koc F, Hacimuftuoglu A and Bayir Y: Comparative study
on the gastroprotective potential of some antidepressants in
indomethacin-induced ulcer in rats. Chem Biol Interact.
180:318–324. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Zarkovic N: 4-hydroxynonenal as a
bioactive marker of pathophysiological processes. Mol Aspects Med.
24:281–291. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Smathers RL, Galligan JJ, Stewart BJ and
Petersen DR: Overview of lipid peroxidation products and hepatic
protein modification in alcoholic liver disease. Chem Biol
Interact. 192:107–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Pacher P, Beckman JS and Liaudet L: Nitric
oxide and peroxynitrite in health and disease. Physiol Rev.
87:315–424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Chen JH, Tipoe GL, Liong EC, So HS, Leung
KM, Tom WM, Fung PC and Nanji AA: Green tea polyphenols prevent
toxin-induced hepatotoxicity in mice by down-regulating inducible
nitric oxide-derived prooxidants. Am J Clin Nutr. 80:742–751.
2004.PubMed/NCBI
|
|
79
|
Delgado J, Saborido A and Megías A:
Prolonged treatment with the anabolic-androgenic steroid stanozolol
increases antioxidant defences in rat skeletal muscle. J Physiol
Biochem. 66:63–71. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yoo YE and Ko CP: Dihydrotestosterone
ameliorates degeneration in muscle, axons and motoneurons and
improves motor function in amyotrophic lateral sclerosis model
mice. PLoS One. 7:e372582012. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Onda A, Jiao Q, Nagano Y, Akimoto T,
Miyamoto T, Minamisawa S and Fukubayashi T: Acupuncture ameliorated
skeletal muscle atrophy induced by hindlimb suspension in mice.
Biochem Biophys Res Commun. 410:434–439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Gomes MD, Lecker SH, Jagoe RT, Navon A and
Goldberg AL: Atrogin-1, a muscle-specific F-box protein highly
expressed during muscle atrophy. Proc Natl Acad Sci USA.
98:14440–14445. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li HH, Kedar V, Zhang C, McDonough H, Arya
R, Wang DZ and Patterson C: Atrogin-1/muscle atrophy F-box inhibits
calcineurin-dependent cardiac hypertrophy by participating in an
SCF ubiquitin ligase complex. J Clin Invest. 114:1058–1071. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Centner T, Yano J, Kimura E, McElhinny AS,
Pelin K, Witt CC, Bang ML, Trombitas K, Granzier H, Gregorio CC, et
al: Identification of muscle specific ring finger proteins as
potential regulators of the titin kinase domain. J Mol Biol.
306:717–726. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
McElhinny AS, Kakinuma K, Sorimachi H,
Labeit S and Gregorio CC: Muscle-specific RING finger-1 interacts
with titin to regulate sarcomeric M-line and thick filament
structure and may have nuclear functions via its interaction with
glucocor-ticoid modulatory element binding protein-1. J Cell Biol.
157:125–136. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Cohen S, Brault JJ, Gygi SP, Glass DJ,
Valenzuela DM, Gartner C, Latres E and Goldberg AL: During muscle
atrophy, thick, but not thin, filament components are degraded by
MuRF1-dependent ubiquitylation. J Cell Biol. 185:1083–1095. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Berne RM, Knabb RM, Ely SW and Rubio R:
Adenosine in the local regulation of blood flow: A brief overview.
Fed Proc. 42:3136–3142. 1983.PubMed/NCBI
|
|
88
|
Segal SS and Kurjiaka DT: Coordination of
blood flow control in the resistance vasculature of skeletal
muscle. Med Sci Sports Exerc. 27:1158–1164. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Dobson JG Jr, Rubio R and Berne RM: Role
of adenine nucleotides, adenosine, and inorganic phosphate in the
regulation of skeletal muscle blood flow. Circ Res. 29:375–384.
1971. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Vergauwen L, Hespel P and Richter EA:
Adenosine receptors mediate synergistic stimulation of glucose
uptake and transport by insulin and by contractions in rat skeletal
muscle. J Clin Invest. 93:974–981. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Lynge J and Hellsten Y: Distribution of
adenosine A1, A2A and A2B receptors in human skeletal muscle. Acta
Physiol Scand. 169:283–290. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zheng J, Wang R, Zambraski E, Wu D,
Jacobson KA and Liang BT: Protective roles of adenosine A1, A2A,
and A3 receptors in skeletal muscle ischemia and reperfusion
injury. Am J Physiol Heart Circ Physiol. 293:H3685–H3691. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Caterina MJ, Schumacher MA, Tominaga M,
Rosen TA, Levine JD and Julius D: The capsaicin receptor: A
heat-activated ion channel in the pain pathway. Nature.
389:816–824. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
94
|
Guilak F, Leddy HA and Liedtke W:
Transient receptor potential vanilloid 4: The sixth sense of the
musculoskeletal system? Ann N Y Acad Sci. 1192:404–409. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Mizoguchi F, Mizuno A, Hayata T, Nakashima
K, Heller S, Ushida T, Sokabe M, Miyasaka N, Suzuki M, Ezura Y, et
al: Transient receptor potential vanilloid 4 deficiency suppresses
unloading-induced bone loss. J Cell Physiol. 216:47–53. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Carnac G, Ricaud S, Vernus B and Bonnieu
A: Myostatin: Biology and clinical relevance. Mini Rev Med Chem.
6:765–770. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Gonzalez-Cadavid NF, Taylor WE, Yarasheski
K, Sinha-Hikim I, Ma K, Ezzat S, Shen R, Lalani R, Asa S, Mamita M,
et al: Organization of the human myostatin gene and expression in
healthy men and HIV-infected men with muscle wasting. Proc Natl
Acad Sci USA. 95:14938–14943. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Haigis MC and Guarente LP: Mammalian
sirtuins - emerging roles in physiology, aging, and calorie
restriction. Genes Dev. 20:2913–2921. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Amat R, Planavila A, Chen SL, Iglesias R,
Giralt M and Villarroya F: SIRT1 controls the transcription of the
peroxisome proliferator-activated receptor-gamma
Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through
the PGC-1alpha autoregulatory loop and interaction with MyoD. J
Biol Chem. 284:21872–21880. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Toledo M, Busquets S, Ametller E,
López-Soriano FJ and Argilés JM: Sirtuin 1 in skeletal muscle of
cachectic tumour-bearing rats: A role in impaired regeneration? J
Cachexia Sarcopenia Muscle. 2:57–62. 2011. View Article : Google Scholar : PubMed/NCBI
|
